Pro-life official urges Congress to suspend FDA approval of RU-486

Published: 2006-03-20

WASHINGTON (CNS) -- A spokeswoman for the U.S. bishops' pro-life secretariat, responding to a report that two more women have died after taking RU-486, called on Congress to pass legislation that aims to suspend the Food and Drug Administration's approval of the drug used for chemical abortions. "We are deeply saddened by yet another advisory from the Food and Drug Administration that two more women have died from RU-486 abortions," said Deirdre A. McQuade, director of planning and information for the U.S. bishops' Secretariat for Pro-Life Activities. However, in its March 17 public health advisory, the FDA said it was not yet "able to confirm the causes of death" of the two women in the United States but was "investigating all circumstances associated with these cases." The agency said it had received "verbal notification" of the deaths by the manufacturer of RU-486, Danco Laboratories. McQuade said 10 women have died after using the regimen.

Copyright (c) 2006 Catholic News Service /U.S. Conference of Catholic Bishops. The CNS news report may not be published, broadcast, rewritten or otherwise distributed, including but not limited to such means as framing or any other digital copying or distribution method, in whole or in part without the prior written authority of Catholic News Service .